Microalgae grow rapidly, require minimal space, can proliferate in non-agricultural land, do not compete with human food sources, and can be cultivated in a variety of environments, including wastewater. They are considered an ecological source of bioactive compounds, offering an environmentally friendly alternative to conventional industrial production methods, which are often resource-intensive. It is important to emphasize that both the species of microalgae and the specific culture conditions play a decisive role in the generation and storage of valuable bioactive compounds, which can act as biostimulants. Biostimulants are organic compounds or microorganisms capable of enhancing crop quality parameters by optimizing nutrient and water use efficiency, while also strengthening tolerance to abiotic stress. The aim of this article is to provide an updated understanding of biostimulants, their modes of action, and their role in regulating plant responses to abiotic stress. It further incorporates examples of successful trials that demonstrate the advantageous applications of microalgae-based biostimulants, while also addressing the barriers and limitations to their commercialization and integration into sustainable agricultural practices.
Background/Objectives: Tyrosinemia type 1 (HT-1) is a treatable inherited disorder characterized by disrupted tyrosine metabolism, leading to severe liver, renal, and occasionally neurological dysfunction. Early diagnosis by newborn screening markedly reduces the risk of hepatocellular carcinoma (HCC), the most serious complication. A deeper understanding of HT-1 pathophysiology is necessary to prevent disease complications and improve diagnostic and therapeutic strategies. This study explored the untargeted serum metabolomic profiles of HT-1 patients. Methods: High-resolution untargeted metabolomics coupled with liquid chromatography was applied for serum analysis of 16 late-diagnosed Chilean HT-1 patients on nitisinone (NTBC) therapy and 16 age- and sex-matched controls. The statistically significant up- and down-regulated features were used for annotation and association with different metabolic pathways. Results: Untargeted metabolomics revealed 1066 features significantly changed in HT-1 patients. Increased metabolites included aromatic compounds, medium- and long-chain acyl-carnitines, bile acids (prevalently taurine-conjugated), indole-based compounds, modified nucleosides and nucleobases. Decreased metabolites were mainly related to lipid class, including lysophosphatidylcholines, lysophosphatidic acids, long-chain fatty acids, and acylglycerols. Conclusions: Untargeted metabolomics showed perturbation of tyrosine- and tryptophan-related pathways and described a novel HT-1 metabolomic pattern demonstrating net dysregulation of lipid and bile acid metabolism in NTBC-treated patients with delay diagnoses. Increased acylcarnitines, taurine-conjugated bile acids, modified nucleobases, and reduced lysophosphatidylcholines overlap with the metabolomic pattern previously reported in Wnt/β-catenin-associated HCC. Although direct mechanistic link cannot be established in this study, these alterations may reflect persistent disease-related metabolic adaptations and warrant further investigation to clarify their potential relevance with long-term complications.